Showing BioInteractions for Lutetium Lu 177 dotatate (DB13985)

BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting GroupInteracting Drugs
Lutetium Lu 177 dotatate is a Somatostatin receptor type 2 agonist
1Somatostatin receptor type 2 inducersVapreotide
2Somatostatin receptor type 2 agonistsLanreotide, Somatostatin
3Somatostatin receptor type 2 bindersCopper oxodotreotide Cu-64, Dotatate gallium Ga-68
4Somatostatin receptor type 2 ligandsEdotreotide gallium Ga-68
Interacting GroupInteracting Drugs
Lutetium Lu 177 dotatate is a Somatostatin receptor type 1 agonist
1Somatostatin receptor type 1 agonistsSomatostatin
2Somatostatin receptor type 1 ligandsEdotreotide gallium Ga-68
Interacting GroupInteracting Drugs
Lutetium Lu 177 dotatate is a Somatostatin receptor type 3 agonist
1Somatostatin receptor type 3 agonistsSomatostatin
2Somatostatin receptor type 3 ligandsEdotreotide gallium Ga-68
Interacting GroupInteracting Drugs
Lutetium Lu 177 dotatate is a Somatostatin receptor type 4 agonist
1Somatostatin receptor type 4 agonistsSomatostatin
Interacting GroupInteracting Drugs
Lutetium Lu 177 dotatate is a Somatostatin receptor type 5 agonist
1Somatostatin receptor type 5 agonistsLanreotide, Somatostatin, Vapreotide
2Somatostatin receptor type 5 ligandsEdotreotide gallium Ga-68